Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

HIV Infection

Free Subscription 27.08.2018 12 AIDS 1 AIDS Res Hum Retroviruses 2 Ann Intern Med 3 Clin Infect Dis 1 Int J Cancer 1 Int J Dermatol 4 J Acquir Immune Defic Syndr 3 J Infect Dis 2 J Med Virol 2 Lancet Gastroenterol Hepatol 6 Lancet HIV 11 PLoS One 1 PLoS Pathog 1 Science

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS

1. PELCHEN-MATTHEWS A, Ryom L, Borges AH, Edwards S, et al
   Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort.
   AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001967.
   PubMed     Text format     Abstract available
   
   
2. MOMPER JD, Best BM, Wang J, Capparelli EV, et al
   Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV.
   AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001992.
   PubMed     Text format     Abstract available
   
   
3. WANG R, Haberlen SA, Palella FJ Jr, Mugavero MJ, et al
   Viremia copy-years and mortality among cART-initiating HIV-positive individuals: how much viral load history is enough?
   AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001986.
   PubMed     Text format     Abstract available
   
   
4. SHADE SB, Osmand T, Luo A, Aine R, et al
   Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the search study.
   AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001958.
   PubMed     Text format     Abstract available
   
   
5. MILANINI B, Paul R, Bahemana E, Adamu Y, et al
   Limitations of the international HIV dementia scale in the current era.
   AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001968.
   PubMed     Text format     Abstract available
   
   
6. PISKE M, Budd MA, Qiu AQ, Maan EJ, et al
   Neurodevelopmental outcomes and in utero antiretroviral exposure in HIV-exposed uninfected children.
   AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001985.
   PubMed     Text format     Abstract available
   
   
7. KALAYJIAN RC, Albert JM, Cremers S, Gupta SK, et al
   Women have enhanced bone loss associated with phosphaturia and CD4 cell restoration during initial antiretroviral therapy.
   AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001995.
   PubMed     Text format     Abstract available
   
   
8. KANTOR R, Delong A, Schreier L, Reitsma M, et al
   HIV Second-Line Failure and Drug Resistance at High- and Low-Level Viremia in Western Kenya.
   AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001964.
   PubMed     Text format     Abstract available
   
   
9. VAN DER HEIJDEN WA, van Crevel R, De Groot PG, Urbanus RT, et al
   A Switch to a raltegravir containing regimen does not lower platelet reactivity in HIV-infected individuals.
   AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001993.
   PubMed     Text format     Abstract available
   
   
10. DAVY-MENDEZ T, Eron JJ, Brunet L, Zakharova O, et al
    New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001990.
    PubMed     Text format     Abstract available
    
    
11. ERLANDSON KM, MaWhinney S, Wilson M, Gross L, et al
    Physical function improvements with moderate or high-intensity exercise among older adults with or without HIV infection.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001984.
    PubMed     Text format     Abstract available
    
    
12. TCHAKOUTE CT, Sainani KL, Osawe S, Datong P, et al
    Breastfeeding mitigates the effects of maternal HIV on infant infectious morbidity in the Option B+ era: A multicenter prospective cohort study.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001974.
    PubMed     Text format     Abstract available
    
    

    
    AIDS Res Hum Retroviruses

13. MADANI N, Alipour Darvishi Z, Doroudi F
    Fuzzy modeling of the enactment of stigma by healthcare personnel toward people living with HIV in the frame of counterfactual thinking: A mixed-method approach.
    AIDS Res Hum Retroviruses. 2018 Aug 21. doi: 10.1089/AID.2018.0166.
    PubMed     Text format     Abstract available
    
    

    
    Ann Intern Med

14. NANCE RM, Delaney JAC, Simoni JM, Wilson IB, et al
    HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.
    Ann Intern Med. 2018 Aug 21. pii: 2697568. doi: 10.7326/M17-2242.
    PubMed     Text format     Abstract available
    
    
15. MARSTON HD, Dieffenbach CW, Fauci AS
    Ending the HIV Epidemic in the United States: Closing the Implementation Gaps.
    Ann Intern Med. 2018 Aug 21. pii: 2698044. doi: 10.7326/M18-1944.
    PubMed     Text format    
    
    

    
    Clin Infect Dis

16. CASTILLO-MANCILLA JR, Morrow M, Coyle RP, Coleman SS, et al
    Tenofovir Diphosphate in Dried Blood Spots is Strongly Associated with Viral Suppression in Individuals with HIV infection.
    Clin Infect Dis. 2018 Aug 23. pii: 5078212. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
17. EL KAMARI V, Moser C, Hileman CO, Currier JS, et al
    Lower pretreatment gut integrity is independently associated with fat gain on antiretroviral therapy.
    Clin Infect Dis. 2018 Aug 23. pii: 5078204. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
18. ROBERTSON K, Oladeji B, Jiang H, Kumwenda J, et al
    HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction.
    Clin Infect Dis. 2018 Aug 20. pii: 5076927. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

19. JOSHI S, Muwonge R, Kulkarni V, Deodhar K, et al
    Incidence of cervical intraepithelial neoplasia in women infected with human immunodeficiency virus (HIV) with no evidence of disease at baseline: results of a prospective cohort study with up to 6.4 years of follow-up from India.
    Int J Cancer. 2018 Aug 22. doi: 10.1002/ijc.31826.
    PubMed     Text format     Abstract available
    
    

    
    Int J Dermatol

20. TITOU H, Ebongo C, Hjira N
    Dermatologic manifestations among human immunodeficiency virus patients in Morocco and association with immune status.
    Int J Dermatol. 2018;57:156-161.
    PubMed     Text format     Abstract available
    
    

    
    J Acquir Immune Defic Syndr

21. LI Y, Nouraie SM, Kessinger C, Weinman R, et al
    Factors Associated with Progression of Lung Function Abnormalities in HIV-Infected Individuals.
    J Acquir Immune Defic Syndr. 2018 Aug 16. doi: 10.1097/QAI.0000000000001840.
    PubMed     Text format     Abstract available
    
    
22. DAVY-MENDEZ T, Napravnik S, Zakharova O, Kuruc J, et al
    Acute HIV Infection and CD4/CD8 Ratio Normalization after Antiretroviral Therapy Initiation.
    J Acquir Immune Defic Syndr. 2018 Aug 16. doi: 10.1097/QAI.0000000000001843.
    PubMed     Text format     Abstract available
    
    
23. JALIL EM, Grinsztejn B, Velasque L, Makkeda AR, et al
    Awareness, willingness and PrEP eligibility among transgender women in Rio de Janeiro, Brazil.
    J Acquir Immune Defic Syndr. 2018 Aug 16. doi: 10.1097/QAI.0000000000001839.
    PubMed     Text format     Abstract available
    
    
24. OLDENBURG CE, Ortblad KF, Chanda MM, Mwale M, et al
    Intimate Partner Violence and Antiretroviral Therapy Initiation Among Female Sex Workers Newly Diagnosed with HIV in ZAMBIA: A Prospective Study.
    J Acquir Immune Defic Syndr. 2018 Aug 16. doi: 10.1097/QAI.0000000000001841.
    PubMed     Text format     Abstract available
    
    

    
    J Infect Dis

25. PUDNEY J, Wangu Z, Panther L, Fugelso D, et al
    Condylomata acuminata (anogenital warts) contain accumulations of HIV-1 target cells that may provide portals for HIV transmission.
    J Infect Dis. 2018 Aug 18. pii: 5076076. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
26. CHOW FC, Makanjuola A, Wu K, Berzins B, et al
    Physical activity is associated with lower odds of cognitive impairment in women but not men living with HIV infection.
    J Infect Dis. 2018 Aug 18. pii: 5075993. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
27. RICHTERMAN A, Sainvilien DR, Eberly L, Ivers LC, et al
    Individual and Household Risk Factors for Symptomatic Cholera Infection: A Systematic Review and Meta-analysis.
    J Infect Dis. 2018 Aug 18. pii: 5076163. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Med Virol

28. GILANI US, Memoona, Rasheed A, Shahid M, et al
    The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.
    J Med Virol. 2018 Aug 22. doi: 10.1002/jmv.25292.
    PubMed     Text format     Abstract available
    
    
29. JORDIER F, Deligny ML, Barre R, Robert C, et al
    Human pegivirus (HPgV) isolates characterized by deep sequencing from HCV- and HIV-RNA positive blood donations, France.
    J Med Virol. 2018 Aug 22. doi: 10.1002/jmv.25290.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

30. THE LANCET GASTROENTEROLOGY HE
    The Global Fund and Heineken.
    Lancet Gastroenterol Hepatol. 2018;3:213.
    PubMed     Text format    
    
    
31. SPEARMAN CW, Afihene M, Ally R, Apica B, et al
    Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets.
    Lancet Gastroenterol Hepatol. 2017;2:900-909.
    PubMed     Text format     Abstract available
    
    

    
    Lancet HIV

32. JANURAGA PP, Reekie J, Mulyani T, Lestari BW, et al
    The cascade of HIV care among key populations in Indonesia: a prospective cohort study.
    Lancet HIV. 2018 Aug 21. pii: S2352-3018(18)30148.
    PubMed     Text format     Abstract available
    
    
33. HANRAHAN C, Dowdy D
    Chest X-ray for tuberculosis preventive therapy: use caution.
    Lancet HIV. 2018 Aug 20. pii: S2352-3018(18)30213.
    PubMed     Text format    
    
    
34. HAMADA Y, Lujan J, Schenkel K, Ford N, et al
    Sensitivity and specificity of WHO's recommended four-symptom screening rule for tuberculosis in people living with HIV: a systematic review and meta-analysis.
    Lancet HIV. 2018 Aug 20. pii: S2352-3018(18)30137.
    PubMed     Text format     Abstract available
    
    
35. VAN LUENEN S, Garnefski N, Spinhoven P, Kraaij V, et al
    Guided internet-based intervention for people with HIV and depressive symptoms: a randomised controlled trial in the Netherlands.
    Lancet HIV. 2018 Aug 17. pii: S2352-3018(18)30133.
    PubMed     Text format     Abstract available
    
    
36. KARYOTAKI E
    Internet-based interventions for people with HIV and depression.
    Lancet HIV. 2018 Aug 17. pii: S2352-3018(18)30172.
    PubMed     Text format    
    
    
37. POUDEL KC, Jimba M
    HIV care continuum for key populations in Indonesia.
    Lancet HIV. 2018 Aug 21. pii: S2352-3018(18)30169.
    PubMed     Text format    
    
    

    
    PLoS One

38. AVONG YK, Jatau B, Gurumnaan R, Danat N, et al
    Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study.
    PLoS One. 2018;13:e0200810.
    PubMed     Text format     Abstract available
    
    
39. CHINGONZOH R, Manesen MR, Madlavu MJ, Sopiseka N, et al
    Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
    PLoS One. 2018;13:e0202469.
    PubMed     Text format     Abstract available
    
    
40. BATES MJ, Mphwatiwa T, Ardrey J, Desmond N, et al
    Household concepts of wellbeing and the contribution of palliative care in the context of advanced cancer: A Photovoice study from Blantyre, Malawi.
    PLoS One. 2018;13:e0202490.
    PubMed     Text format     Abstract available
    
    
41. TAFUMA TA, Mahachi N, Dziwa C, Marowa P, et al
    Time taken to link newly identified HIV positive clients to care following a home-base index case HIV testing: Experience from two provinces in Zimbabwe.
    PLoS One. 2018;13:e0201018.
    PubMed     Text format     Abstract available
    
    
42. VINCENT KL, Moss JA, Marzinke MA, Hendrix CW, et al
    Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc.
    PLoS One. 2018;13:e0201952.
    PubMed     Text format     Abstract available
    
    
43. KOHATSU L, Bolu O, Schmitz ME, Chang K, et al
    Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube.
    PLoS One. 2018;13:e0202018.
    PubMed     Text format     Abstract available
    
    
44. PAPARINI S, Nutland W, Rhodes T, Nguyen VK, et al
    DIY HIV prevention: Formative qualitative research with men who have sex with men who source PrEP outside of clinical trials.
    PLoS One. 2018;13:e0202830.
    PubMed     Text format     Abstract available
    
    
45. TRAN VT, Mama Djima M, Messou E, Moisan J, et al
    Avoidable workload of care for patients living with HIV infection in Abidjan, Cote d'Ivoire: A cross-sectional study.
    PLoS One. 2018;13:e0202911.
    PubMed     Text format     Abstract available
    
    
46. POWER J, Westle A, Dowsett GW, Lucke J, et al
    Perceptions of HIV cure research among people living with HIV in Australia.
    PLoS One. 2018;13:e0202647.
    PubMed     Text format     Abstract available
    
    
47. KRUSI A, Ranville F, Gurney L, Lyons T, et al
    Positive sexuality: HIV disclosure, gender, violence and the law-A qualitative study.
    PLoS One. 2018;13:e0202776.
    PubMed     Text format     Abstract available
    
    
48. WHITMILL A, Kim S, Rojas V, Gulraiz F, et al
    Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.
    PLoS One. 2018;13:e0202524.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Pathog

49. NGANOU-MAKAMDOP K, Billingsley JM, Yaffe Z, O'Connor G, et al
    Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication.
    PLoS Pathog. 2018;14:e1007246.
    PubMed     Text format     Abstract available
    
    

    
    Science

50. COHEN J
    Monthly shots may replace daily anti-HIV pills.
    Science. 2018;361:740.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: